The $2.7B Pre­ci­sion/Eli Lil­ly deal gets mod­i­fied; Abeona clos­es $25M di­rect of­fer­ing

A deal be­tween Pre­ci­sion Bio­Sciences and Eli Lil­ly has now been mod­i­fied with low­er mile­stones.

Pre­ci­sion an­nounced the change in an SEC fil­ing, say­ing the com­pa­nies en­tered the mod­i­fied terms on June 30 af­ter Lil­ly as­signed the Pre­ci­sion deal to its sub­sidiary Pre­vail Ther­a­peu­tics in No­vem­ber. The drug­mak­er made the deal with Pre­ci­sion in No­vem­ber 2020, and ac­quired Pre­vail in De­cem­ber of the same year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER